• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. SFX SPI PDS+ BI VIO 18IN2 USP1 D/A CTX; SUTURE, SURGICAL, ABSORBABLE, POLYDIOXANONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. SFX SPI PDS+ BI VIO 18IN2 USP1 D/A CTX; SUTURE, SURGICAL, ABSORBABLE, POLYDIOXANONE Back to Search Results
Catalog Number SXPP2B436
Medical Device Problem Code Material Separation (1562)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/14/2025
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that a patient underwent an unknown procedure on (b)(6) 2025 and barbed suture was used.During the procedure, it was reported to the sales rep that the needle is keep pooping of the suture it happen three time a row with different patients and procedure.Product is not for return.No adverse patient consequences were reported.Additional information was requested.
 
Additional Manufacturer Narrative
Product complaint # (b)(4) this report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.H6 component code: g07002 - no device problem found.H3 investigation summary: the product was returned to ethicon for evaluation.Twelve representative unopened samples were received for analysis.Product code sxpp2b436.To evaluate the condition of the returned samples, the packets were opened.The swage and attachment area were noted to be as expected.The sutures were dispensed and examined along the strands and no anomalies were observed during evaluation.Functional test was performed using an instron equipment, and the pull force did not meet the minimum requirements in one sample.Further investigation was conducted on this sample, revealing that the end insertion of the suture did not meet the specified requirements.No anomalies were observed in the remaining eleven samples during the evaluation.Based on the information currently available, the short insertion issue was identified as pull out during the investigation of the sample received.This product issue will be addressed through the ethicon quality system.H3 investigation summary: the product was returned to ethicon for evaluation.Two needle- suture pieces and one suture piece were received for analysis.Product code sxpp2b436; the product code is double armed.During visual inspection of the returned sample, the swage and attachment areas appeared as expected.However, marks consistent with contact from a surgical instrument were observed on the needle bodies, and one needle tip was bent.The suture pieces were attached to the needle barrel holes.Overall, no needle pull-off was observed.The sutures pieces were examined, and the extremes of the sutures were noted to be cut probably caused by a surgical instrument.In addition, body fluids were noted on the strands.The product code sxpp2b436 contains an absorbable suture.Since the samples were received open, the functional test could not be performed due to undetermined exposure to the environment.As part of the ethicon quality process, all devices are manufactured, inspected, and released to approved specifications.The event described could not be confirmed as no issues related to pull off - suture needle were noted.Although no product defect was identified, there may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the laboratory analysis.Additional information was requested, and the following was obtained via: confirm whether the devices used in the three procedures were physically from lot 108xqb or from lot 103p0l.103p0l confirm whether any of the 14 devices from lot 103p0l exhibited the needle separation.Yes we have had multiples needle separations from the lot 103p0l.We sent those in because the surgeon no longer feels comfortable using this lot #.If available, please provide lot numbers for the actual devices used during each procedure.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Date sent to the fda: 1/21/2026.Corrected information: h6 investigational codes.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SFX SPI PDS+ BI VIO 18IN2 USP1 D/A CTX
Common Device Name
SUTURE, SURGICAL, ABSORBABLE, POLYDIOXANONE
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON INC.-SAN LORENZO PR
road 183, km 8.3
san lorenzo PR 00754
Manufacturer Contact
orla o'mahony
1000 route 202
raritan, NJ 08869
3035526892
MDR Report Key24014177
Report Number2210968-2026-00203
Device Sequence Number9191450
Product Code NEW
UDI-Device Identifier10705031464575
UDI-Public(01)10705031464575(17)270531(10)108XQB
Combination Product (Y/N)Y
Initial Reporter StateKY
Initial Reporter CountryUS
PMA/510(K) Number
K192144
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 01/08/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/31/2026
Device Catalogue NumberSXPP2B436
Device Lot Number103P0L
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/05/2026
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/20/2025
Supplement Date Received by Manufacturer01/12/2026
Initial Report FDA Received Date01/08/2026
Supplement Report FDA Received Date01/21/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured09/27/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-